Biomarkers in Alzheimer's disease drug development-Reference-Cited by-同舟云学术

Biomarkers in Alzheimer's disease drug development

Published:2011-05 Issue:3 Volume:7 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Cummings Jeffrey L.¹

Affiliation:

1. Cleveland Clinic Lou Ruvo Center for Brain HealthCleveland Clinic Neurological InstituteLas Vegas, ClevelandNV, OHUSA

Funder

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2010.06.004

Reference330 articles.

1. Disease‐modifying therapies in Alzheimer's disease

2. Alzheimer's Disease

3. Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer’s disease

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives;IBRO Neuroscience Reports;2024-06

2. Considerations for use of blood-based biomarkers in epidemiologic dementia research;American Journal of Epidemiology;2023-10-16

3. Early Detection of Alzheimer’s Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers;Journal of Alzheimer's Disease;2023-04-04

4. Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study;Aging;2022-09-06

5. Detection of Amyloid-β(1–42) Aggregation With a Nanostructured Electrochemical Sandwich Immunoassay Biosensor;Frontiers in Bioengineering and Biotechnology;2022-03-16